Amgen

Other News

News Update

New Phase 2 Data Showed that Litifilimab Significantly Reduced Disease Activity in Cutaneous Lupus Erythematosus 

March 30, 2026
Lupus Therapeutics, clinical affiliate of the Lupus Research Alliance, welcomes new results from the Phase 2 part of the...
News Update

Stay Well with Lupus: Tips for Meditation, Movement, and Stress Management 

March 24, 2026
Living with lupus means managing physical symptoms, emotional ups and downs, and the everyday challenges that come with an autoimmune...
Press Release

New Phase 3 Study Shows that Gazyva® (obinutuzumab) Significantly Reduces Lupus Disease Activity in SLE

March 6, 2026
A new Phase 3 study published in the New England Journal of Medicine found that Gazyva® (obinutuzumab) significantly reduced disease activity...